Table 2.
Extent of disease | n (%) |
---|---|
Local | 28 (74) |
Metastatic | 10 (26) |
Current Cancer Therapy | |
Chemotherapy | 32 (84) |
Hormonal Therapy | 3 (8) |
Chemotherapy and Hormonal Therapy | 3 (8) |
ECOG Performance Status | |
0 | 13 (34) |
1 | 22 (58) |
2 | 3 (8) |
Symptom Inventories Baseline | Mean (Range) |
Brief Fatigue Inventory | 5.7 (4.1–8.6) |
Beck Depression Index-II | 11.2 (2.0–19.0) |
Brief Sleep Disturbance Scale | 21.1 (5.0–40.0) |
Profile of Moods States | |
Tension | 4.4 (0–15.0) |
Depression | 2.9 (0–15.0) |
Anger | 3.5 (0–15.0) |
Vigor | 4.3 (0–18.0) |
Fatigue | 12.5 (1.0–20.0) |
Confusion | 3.9 (0–10.0) |
MD Anderson Symptom Inventory | |
Severity | 3.1 (0.6–5.9) |
Interference | 3.9 (0.5–7.0) |
Hemoglobin (g/dL) Mean; (range) | 11.7 (9.8–13.8) |
Abbreviations: ECOG, Eastern Cooperative Oncology Group.